NCT03611686View on ClinicalTrials.gov

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

Active, not recruitingOBSERVATIONAL

Enrollment

219

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Metastatic Prostate Adenocarcinoma

Interventions

DRUG

Local chemotherapy

Local chemotherapy will be administrated according to local recommendation

Trial Locations (1)

Unknown

Rouen University Hospital, Rouen

All Listed Sponsors

lead

University Hospital, Rouen

OTHER

NCT03611686 - Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies | Biotech Hunter | Biotech Hunter